MX9804957A - PROCESO PARA LA PREPARACION DE ESTEROIDES DE 9, 11- beta-EPOXIDO. - Google Patents

PROCESO PARA LA PREPARACION DE ESTEROIDES DE 9, 11- beta-EPOXIDO.

Info

Publication number
MX9804957A
MX9804957A MX9804957A MX9804957A MX9804957A MX 9804957 A MX9804957 A MX 9804957A MX 9804957 A MX9804957 A MX 9804957A MX 9804957 A MX9804957 A MX 9804957A MX 9804957 A MX9804957 A MX 9804957A
Authority
MX
Mexico
Prior art keywords
beta
preparation
bromoformate
chloroformate
produce
Prior art date
Application number
MX9804957A
Other languages
English (en)
Spanish (es)
Inventor
Xiaoyong Fu
Tiruvettipuram Thiruvengadam
Chuo-Hong Tann
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9804957A publication Critical patent/MX9804957A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
MX9804957A 1995-12-20 1998-06-19 PROCESO PARA LA PREPARACION DE ESTEROIDES DE 9, 11- beta-EPOXIDO. MX9804957A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57556295A 1995-12-20 1995-12-20

Publications (1)

Publication Number Publication Date
MX9804957A true MX9804957A (es) 1998-09-30

Family

ID=24300812

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9804957A MX9804957A (es) 1995-12-20 1998-06-19 PROCESO PARA LA PREPARACION DE ESTEROIDES DE 9, 11- beta-EPOXIDO.

Country Status (12)

Country Link
EP (1) EP0873352A1 (no)
JP (1) JP2000502102A (no)
KR (1) KR20000064495A (no)
CN (1) CN1209138A (no)
AU (1) AU1331097A (no)
BR (1) BR9612064A (no)
CZ (1) CZ191398A3 (no)
IL (1) IL125004A0 (no)
MX (1) MX9804957A (no)
NO (1) NO982877L (no)
PL (1) PL327141A1 (no)
WO (1) WO1997022616A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207151B2 (en) 2008-05-28 2012-06-26 Validus Biopharma Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
CN103588853A (zh) * 2013-11-28 2014-02-19 浙江省天台县奥锐特药业有限公司 制备9,11β-环氧甾族化合物的方法
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
CN107266519B (zh) * 2016-04-08 2021-06-29 天津金耀集团有限公司 一种9β,11β-环氧-17α-羟基-16α-甲基-21-氯代-1,4孕甾二烯-3,20-二酮新晶型及其制备方法
CN109180767A (zh) * 2018-09-04 2019-01-11 浙江仙琚制药股份有限公司 一种制备糠酸莫米松的方法
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1145170B (de) * 1959-03-13 1963-03-14 Scherico Ltd Verfahren zur Herstellung von 9,11-Oxidosteroiden der Androstan- und Pregnanreihe
GB1244604A (en) * 1967-08-25 1971-09-02 Organon Labor Ltd Substituted methylene steroids and their preparation
GB1416427A (en) * 1972-01-12 1975-12-03 Akzo Nv Alkylated pregnanes and process for obtaining same
DE2617655C2 (de) * 1976-04-21 1984-11-08 F. Hoffmann-La Roche & Co Ag, Basel Kortikoide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE3064460D1 (en) * 1979-01-24 1983-09-08 Akzo Nv Novel alkylated pregnanes, processes for their preparation and pharmaceutical compositions containing same
DD268954A1 (de) * 1983-04-22 1989-06-14 Jenapharm Veb Verfahren zur herstellung von 9alpha-halogen-11beta-formyloxysteroiden der pregnanreihe
FR2675146A1 (fr) * 1991-04-10 1992-10-16 Roussel Uclaf Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.

Also Published As

Publication number Publication date
CN1209138A (zh) 1999-02-24
NO982877D0 (no) 1998-06-19
PL327141A1 (en) 1998-11-23
NO982877L (no) 1998-08-20
EP0873352A1 (en) 1998-10-28
AU1331097A (en) 1997-07-14
JP2000502102A (ja) 2000-02-22
IL125004A0 (en) 1999-01-26
CZ191398A3 (cs) 1998-11-11
KR20000064495A (ko) 2000-11-06
WO1997022616A1 (en) 1997-06-26
BR9612064A (pt) 1999-02-23

Similar Documents

Publication Publication Date Title
KR880000433A (ko) 이미다조피리딘 및 중간체 화합물의 제조방법
HUT55338A (en) Process for producing thienopyridine-phenylacetate derivatives and alpha-bromo-phenyl-acetic acid intermediates
MX9804957A (es) PROCESO PARA LA PREPARACION DE ESTEROIDES DE 9, 11- beta-EPOXIDO.
Coppola et al. Acetylenic Amides. I. Synthesis of N-Substituted-2-propynamides
NO177496B (no) Fremgangsmåte ved fremstilling av mono-N-alkylerte polyazamakrocykler
Hojo et al. NEW SYNTHETIC REACTIONS BASED ON 1-METHYL-2-FLUOROPYRIDINIUM SALTS. STEREOSPECIFIC PREPARATION OF THIOALCOHOLS FROM ALCOHOLS
TW336937B (en) Purification process for crystallizing d4T polymorphic form I
Štefane et al. 3-Acyl-1, 3-diaryltriazenes as neutral and selective acylating agents
FURUKAWA et al. Novel One-step Preparation of Sulfinic Acid Derivatives from Sulfinic Acid
US3649687A (en) 1 3 5-cyclohexane tricarbonyl chloride
ES483249A1 (es) Procedimiento para la obtencion de diciclopentilen(2,2'-bis (4-alquil-6-t-butilfenoles).
JPS60185759A (ja) 4,4′−ジヒドロキシジフエニルジスルフイドの製造方法
US4049708A (en) Fluorodesulfurization of alkyl mercaptans or alkyl dithianes
JPS5890571A (ja) 新規な中員環アミドスルフイド化合物及びその合成法
AU7108491A (en) Improved process for synthesis of 5alpha-cholest-8(14)-en- 3beta-ol-15-one and other 15-oxygenated sterols
JPS6434996A (en) Fluorocyclopentane derivative and production thereof
US4252731A (en) Preparation of steroidal carbamates
Ando et al. Novel ring transformation of thiazolidine to oxazolidine: acyl halide-promoted intramolecular rearrangement of 4 (R)-hydroxymethyl-3-methyl-1, 3-thiazolidine
KR970042559A (ko) 세펨 유도체의 간단한 제조방법
KR950008475A (ko) N-알킬아세트아미드의 제조 방법
JPS54122255A (en) Phosphorus-containing vinylphenol derivative and its preparation
AT374205B (de) Verfahren zur herstellung eines neuen delta 1,4,17-bisnovcholansaeure-derivates
Yang et al. A Mild and Efficient Method for Selective Acetylation of Amines
EP0695290A1 (de) N-fluorsulfonimide, verfahren zu ihrer herstellung sowie deren verwendung als fluorierungsmittel
KR900002874B1 (ko) 아실우레이도 페니실린 유도체의 제조방법